Company

Somatic Labs

AI-powered drug development platform that automates systematic literature reviews, compressing a multi-year regulatory requirement to hours

AIHealthcare & Biotech

People

Samuel Humefounder

News

Interviews (1)

Somatic Labs co-founder on cutting drug review from two years to four hours with AI — and the pancreatic cancer breakthrough at ASCO